Next Article in Journal
Dietary Fatty Acids Contribute to Maintaining the Balance between Pro-Inflammatory and Anti-Inflammatory Responses during Pregnancy
Previous Article in Journal
Effectiveness of Food-Based Intervention to Improve the Linear Growth of Children under Five: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Need for Multidimensional and Multidisciplinary Management of Depressed Preadolescents and Adolescents: A Review of Randomized Controlled Trials on Oral Supplementations (Omega-3, Fish Oil, Vitamin D3)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023)

by
Magdalena Zielińska
*,
Edyta Łuszczki
and
Katarzyna Dereń
Institute of Health Sciences, College of Medical Sciences, University of Rzeszow, 35-959 Rzeszow, Poland
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(11), 2433; https://doi.org/10.3390/nu15112433
Submission received: 14 April 2023 / Revised: 18 May 2023 / Accepted: 22 May 2023 / Published: 23 May 2023
(This article belongs to the Special Issue Nutrition, Sleep, Physical Activity and Mood Disorders)

Abstract

:
Depression is classified as one of the most common mental disorders. Its prevalence has recently increased, becoming a growing public health threat. This review focuses on clarifying the role and importance of individual nutrients in the diet and the impact of nutrient deficiencies on the risk of depression. Deficiencies in nutrients such as protein, B vitamins, vitamin D, magnesium, zinc, selenium, iron, calcium, and omega-3 fatty acids have a significant impact on brain and nervous system function, which can affect the appearance of depressive symptoms. However, it is important to remember that diet in itself is not the only factor influencing the risk of or helping to treat depression. There are many other aspects, such as physical activity, sleep, stress management, and social support, that also play an important role in maintaining mental health. The data review observed that most of the available analyses are based on cross-sectional studies. Further studies, including prospective cohort, case-control studies, are recommended to draw more reliable conclusions.

1. Introduction

Depression is classified as one of the most common mental disorders [1]. Its prevalence has recently increased, becoming a growing public health threat [1,2,3]. In 2019, the incidence rate of mental disorders was one in eight people worldwide, a significant epidemiological and health proportion [4]. Furthermore, it is suggested that nearly half of the population (around 44%) will experience at least one episode of a mental disorder during their lifetime [5]. Depression can be described as a complex and multicausal disease that involves a number of determinants, for example, biological, genetic, social, psychological, that are interrelated and interact with each other [6]. The prevalence of depressive disorders is also related to age (it most often starts in people between 20 and 40 years of age), gender (women fall twice as often as men), marital status (separated, divorced, widowed, especially for men), but also often to difficult traumatic experiences, for example, from childhood [7,8]. Other disease entities also contribute to the risk of depression, with particularly high prevalence rates associated with metabolic disorders (for example, cardiovascular disease) and autoimmune disorders [9,10]. Currently, a growing number of researchers are seeking answers to the question of whether diet can be a modifiable factor in mental health [11,12]. There is some evidence to suggest that diet and related eating habits may be indirectly related to the risk of onset, severity, and duration of depression [12,13]. Diet and related eating habits have been identified as protective factors against psychiatric disorders, as there are similar biological mechanisms that link depression and cardiometabolic diseases. Based on these, a theory has been presented that a proper diet can improve mental health and prevent the occurrence of depression, as well as its effect on the risk of cardiovascular disease [14,15]. Potential relationships between nutritional deficiencies and mental health are suggested to have some relevance to overall society’s well-being on a global scale, although current evidence is severely limited. Considering their role in depression can provide additional clues to the mechanisms that affect this disease and potentially contribute to the development of primary and secondary prevention strategies. However, it should be noted that scientific evidence on this issue is currently severely limited [16]. There are several treatments for depression, such as pharmacotherapy, psychotherapy, and non-pharmacological somatic treatments; however, as Blackburn writes, the treatment of depression has been suboptimal for 50 years [17,18,19]. Given the delayed onset of therapeutic effects and the desire to minimize side effects, particularly in cases of treatment-resistant depression, there is a growing interest in exploring strategies to accelerate the action of antidepressants [20]. Therefore, it is necessary to explore modifiable risk factors and effective prevention methods for depression [20,21,22]. To our knowledge, reviews have recently been published on the use of dietary interventions for depression in adults [23,24]. In terms of studies assessing the relationship between nutrient intake and risk of depression, some results remain inconclusive, and a comprehensive synthesis of existing data in this area is currently lacking. Therefore, this review focuses on clarifying the role and importance of individual nutrients in the diet and the impact of nutrient deficiencies on the risk of depression.

2. Methodology

The literature on the impact of nutrient deficiencies on depression was reviewed over the last five years (between 2018 and 2023). Internet databases (PubMed, Science Direct, Web of Science, Scopus, and Google Scholar) were searched according to keywords related to depression and nutrition, i.e., “nutritional deficiencies”, “depression”, “vitamin B”, “vitamin D”, “omega-3”, “adult depression”, etc. During the literature analysis, a total of 45 articles were identified that were dedicated to investigating the relationship between the intake of dietary nutrients and the appearance of depressive symptoms. The articles found were described in dedicated chapters and presented in tabular form, allowing the results presented to be compared and made more understandable. Furthermore, in addition to the aforementioned analysis of the scientific literature, a description of the relevance of nutrients for the functioning of the nervous system was made, and previous data indicating their potential impact on the risk of depressive symptoms were presented. Table 1 shows the inclusion and exclusion criteria for the studies in the review.

3. Dietary Nutrient Deficiencies and Risk of Depression

Depression is a heterogeneous disorder that is associated with biological mechanisms such as inflammation, dysregulation of the hypothalamic–pituitary–adrenal axis, dysfunction of the sympathetic and parasympathetic nervous system, and endothelial dysfunction [25]. Neurobiological investigations have revealed that depression is linked to cortical and limbic neuronal atrophy, as well as disrupted connectivity and functioning of neural networks. These changes are the result of structural, functional, and neurochemical deficits, of which problems related to γ-aminobutyric acid (GABA) and glutamate function are particularly relevant [26]. One of the most common hypotheses regarding the pathophysiology of depression suggests that there is also a link between depression and low levels of monoamine neurotransmitters. Reduced levels of serotonin, dopamine, and norepinephrine are observed in depressed individuals [27,28,29]. Synthesis and release of the aforementioned neurotransmitters depend on a number of factors, including changes in plasma composition, which are influenced by, among other things, the presence of nutrients in the diet. In addition, dietary modifications, such as changes in macronutrient, vitamin, and mineral intake, can affect cognitive function by regulating inflammatory processes and influencing molecular systems and cellular processes in the body [30,31]. Consequently, the role of optimising the supply of nutrients in the diet, which are essential for proper brain function and can support monoamine-based drug therapy, is increasingly emphasised in depressive disorders [32,33].

3.1. Macronutrients and Water

There is a scarcity of research that examines the impact of insufficient macronutrient intake in the diet on the likelihood and manifestations of depression. In the context of evaluating the impact of diet on health, including mental health, it is worth considering not only individual macronutrients, but also their proportions and the general diet of an individual [34]. The type and quantity of dietary protein consumed play an important role in the pathophysiology of depressive disorders, as protein serves as a crucial source of amino acids that serve as precursors to neurotransmitters within the brain. These are synthesised from aromatic amino acids, such as serotonin from tryptophan, and norepinephrine from tyrosine or its precursor phenylalanine. Therefore, a deficiency of these amino acids in the diet can result in reduced levels [35]. A study conducted by Kofler et al. showed a significant decrease in the concentrations of the aforementioned amino acids in the brain of individuals exhibiting depressive behaviour [36]. Studies on the impact of fat intake on the risk of depression most often analyse the quality of fat consumed, that is, the composition of fatty acids, and not just the amount of total fat consumed. A diet rich in saturated fatty acids (SFAs), trans fatty acids, may increase the risk of depression, while a diet rich in monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) may reduce the risk of depression, although research is inconclusive [37,38]. The brain uses carbohydrates as a major source of energy, as well as structural and functional components [39]. They can also affect mood and brain function by affecting levels of neurotransmitters such as serotonin, dopamine, and norepinephrine [25]. In addition, the availability of neurotransmitters such as glutamate, acetylcholine, and GABA is modulated by the exogenous glucose supply [40]. A diet based on carbohydrates with a lower glycaemic index can effectively reduce the risk of depression [41]. A significant effect of a high glycaemic load diet was also observed on the risk of depression [42]. It is also worth mentioning a very important part of the diet, fibre, and its potential impact on the prevention of depression [43]. Based on the findings of the present meta-analysis, each 5 g increase in total dietary fibre intake is associated with a 5% reduction in the risk of depression [44]. An inverse significant relationship was observed between the intake of fibre from vegetables and soluble fibre and the likelihood of depression. However, fibre from cereal products, fruit, and insoluble fibre were marginally associated with a reduction in depression. The relationship between dietary water intake and depression is not fully understood, and a cross-sectional study on this topic was found during the review period. Water accounts for 75% of brain mass, and dehydration can affect nervous system function [45]. According to Liska et al., anger, confusion, depression, and fatigue increase with dehydration at ≥1% [46]. The association of the intake of the described nutrients with depressive symptoms is described in Table 2.

3.2. Polyunsaturated Fatty Acids

PUFAs are polyunsaturated fatty acids that the human body cannot synthesise on its own and are provided in the diet or by supplementation [63]. Furthermore, they show pleiotropic effects on neuronal structure and function, have anti-inflammatory effects, modulate neuroendocrine pathways, and activate key neurotransmitters, which can contribute to the prevention of depression [64,65]. The bulk of the dry weight of the mature brain is made up of fatty acids, with PUFAs making up about 20% of the dry weight. Both omega-3 fatty acids, mainly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and omega-6 fatty acids, mainly arachidonic acid (AA), can be found in the brain [66]. DHA acid plays a key role, as it is quantitatively the most important fatty acid and is essential for the proper functioning of the neuronal membrane [67]. Consumption of omega-3 PUFA at lower levels or lower serum levels of these acids are associated with a higher risk of suicide attempts and an episode of major depression [68]. Supplementation with omega-3 PUFA fatty acids has the potential to demonstrate favourable outcomes in the prevention and management of depressive disorders, although the findings across studies are not consistently conclusive [64,69]. Table 3 shows the scientific studies that evaluated the intake of PUFA in the diet and its effect on the risk of depression.

3.3. Vitamins

3.3.1. Vitamins of the B Group

Vitamin deficiency can be associated with symptoms of mental disorders [76]. Vitamins of the B group, in addition to the range of functions they perform in the human body, are essential for maintaining the normal functioning of the nervous system through the production of monoamine oxidase, DNA synthesis and methylation, and repair and maintenance of phospholipids [77]. In particular, deficiencies in B vitamins, i.e., B1, B6, B9, and B12, have been linked to depression, as they are essential for neuronal function [78,79,80]. They also have a protective effect against hypercysteinaemia, associated with an increased risk of mood disorders [81]. Furthermore, low levels of vitamin B9 and B12 have been associated with a poorer response to antidepressants [82]. Current work by Berkins et al. suggests that dietary intake of vitamin B6 and B12 may have an impact on brain structure. Vegetarians, particularly those who experience depression, can derive benefits from supplementing their diet with vitamins B6, B9, and B12 to promote optimal brain health [83]. The effects of the listed B vitamins on the nervous system and the risk of depression are described in Table 4.
Table 5 shows the current literature on the assessment of the dietary intake of B vitamins in the diet and their impact on the risk of depression. Low levels of the vitamins described can be due to a number of reasons, i.e., comorbidities, for example, multiple sclerosis, in which, according to a paper by Orti et al., patients who consumed less thiamine showed higher levels of depression characteristic of multiple sclerosis [93], old age [94], use of plant-based diets [95], their malabsorption [96], or unbalanced diet, so given the purpose of this review and the inclusion and exclusion criteria, the focus was mainly on dietary deficiencies in adults.

3.3.2. Vitamin D

Vitamin D is a fat-soluble vitamin that is obtained during exposure to sunlight, food, and supplementation. An increasing number of studies confirm its role in the pathophysiology of diseases, including mental illness [104,105]. According to Fipps et al., the risk of depression increases by 8–14% in people with vitamin D deficiency [106]. Several mechanisms can be invoked to account for this phenomenon. One is the presence of vitamin D receptors (VDR) in different parts of the cortex and limbic system [107]. Many of these areas of the brain have been associated with the pathophysiology of depression, and VDRs are also found in the hippocampus, which plays a role in the control of memory and emotional function [108]. Furthermore, vitamin D is a potent regulator of the production of neurotrophic substances, such as brain-derived neurotrophic factor (BDNF), neurotrophin (NT)-3, and nerve growth factor (NGF). Subsequently, vitamin D plays an important modulatory role in regulating immunoinflammatory pathways that are important in the pathophysiology of depression, and lower serum vitamin D levels have been shown in depressed patients compared to controls [109,110,111]. Another hypothesis is the high levels of reactive oxygen species and Ca2+ in nerve cells in individuals deficient in vitamin D [112]. In addition, vitamin D is effective in preventing depression by maintaining serotonin levels at optimal levels and regulating dopamine and norepinephrine levels in the brain [113,114]. Vitamin D deficiency in patients with depression, as well as in the healthy population, is an important health problem. Research focusses mainly on laboratory measurements of serum vitamin D-25-hydroxyvitamin D (25(OH)D) levels [115]. The role of vitamin D in preventing the onset of postnatal depression is particularly highlighted [116]. An interesting area of research in the context of vitamin D and depression is the determination of levels of the vitamin D-binding protein gene. Calcitriol (1,25[OH]2D3) exerts its influence on the quantity and structure of the neurone by means of detoxification pathways, which encompass the inhibition of inducible nitric oxide synthase and the elevation of glutathione levels, together with the regulation of neurotrophin synthesis—all of which represent determinants associated with the development of depressive symptoms [117]. The potential influence of calcitriol on depressive symptoms can be attributed to the existence of the vitamin D receptor, the vitamin D-binding protein (VDBP), and/or the enzyme 1-alpha-hydroxylase, responsible for the conversion of 25(OH)D3 to 1,25(OH)2D3 within the central nervous system [117]. Table 6 shows the results of the studies on dietary intake and serum vitamin D levels and their impact on the risk of depressive symptoms.

3.4. Mineral Components

To date, scientific investigations have focused mainly on elucidating the involvement of minerals, assessing dietary and blood serum deficiencies, in the pathogenesis of depression [119,120]. Several of these, such as magnesium, zinc, iron, copper, and selenium, have been identified as key in the regulation of cell function and neuromodulation, as well as antioxidant activity [119,121]. Studies have shown that insufficient magnesium levels can induce alterations in central nervous system functioning, specifically affecting glutamatergic transmission within the limbic system and the cerebral cortex. These regions of the brain are critical in the pathophysiology of depression cause [122]. According to Pickering et al., magnesium deficiency can affect the secretion of corticotropin-releasing hormone, which, in turn, leads to increased levels of adrenocorticotropic hormone (ACTH). This mechanism may be related to depression by affecting the regulation of the hypothalamic–pituitary–adrenal (HPA) axis [123]. Magnesium is also an antagonist of NMDA receptors (N-methyl-d-aspartate), and its deficiency can lead to its functional overactivity [124]. The NMDA receptor is associated with the flow of calcium ions into nerve cells, which is crucial for their proper functioning. Its excessive activation can lead to increased calcium ion flow, which, in turn, leads to neurotoxicity. The relationship between dietary magnesium intake and serum magnesium levels and the risk of depression is currently inconclusive. It should be noted that serum magnesium represents only ~1% of total magnesium in the body and does not fully reflect intracellular magnesium status.
Research suggests that changes in brain zinc levels are associated with the development of depression and that zinc supplementation may help treat the condition. Zinc supplementation has been shown to support the effects of antidepressants and improve depressive symptoms in some patients [125]. Another possible reason for the antidepressant effect of zinc could be its anti-inflammatory and antioxidant properties [126]. Furthermore, zinc is also an NMDA receptor antagonist [127]. In addition, zinc influences hormonal regulation, including cortisol levels, cellular immune response, neurogenesis, neuronal plasticity, and expression of BDNF in the hippocampus and cortex, and zinc ions regulate synaptic transmission or act as neurotransmitters [128]. Recent scientific investigations have emphasised the importance of zinc transporters (ZincTs) and zinc-sensing GPR39 receptors in the aetiology and therapeutic interventions related to depression [129]. Current evidence from observational studies and RCTs supports the potential benefits of zinc in reducing risk and alleviating depression [130].
According to Chadern, selenium intake is the most associated with depression of all dietary factors considered [131]. Selenium is an essential trace element that is required for the proper functioning of several selenoproteins, including those involved in the defence of antioxidants in the brain and nervous system. In addition, it helps protect cells from oxidative damage, which can lead to inflammation and disease, including neurological diseases [132]. Given its neuromodulatory role in brain function, researchers are increasingly testing the link between selenium and depression, but some of the results are contradictory [133].
In a recently published study by Hongrong et al., the prevalence of depressive symptoms was significantly higher in patients with elevated serum copper levels. Among serum levels of copper, selenium, and zinc, only an association was observed between depressive symptoms and copper levels [134]. These findings are supported by a meta-analysis by Ni et al. suggesting that elevated blood copper levels may be associated with depressive disorders and, therefore, a possible role for copper as a biomarker of depression [135]. Although it can be speculated that the imbalance of copper in the human body may be one of the causes of depression, there are processes in which copper plays an important role in the development and function of the nervous system. These include neurogenesis, synaptogenesis, neurotransmission, cognition, learning and memory processes, and NMDA function [136]. Copper can support the activity of two neurotrophic factors: BDNF and nerve growth factor (NGF). These neurotrophic factors can influence neuronal plasticity and the neural network [137,138]. Taking a monoaminergic approach to depression, the role of copper in the conversion of dopamine to norepinephrine should also be mentioned. The conversion of dopamine to norepinephrine is copper-dependent, as copper ions interact with dopamine β-hydroxylase [139]. Copper deficiency and excess copper can affect brain function. Astrocytes are considered important regulators of the homeostasis of this element [140].
Iron deficiency represents a prevalent nutritional problem on a global scale and can cause iron deficiency anemia, which is one of the most frequently encountered forms of anemia. In particular, there has been a growing focus on investigating iron metabolism and its pivotal role in the context of mental disorders [141]. Norepinephrine has been linked to iron metabolism in the brain, which can affect the neuroplasticity and function of prefrontal neurones and the hippocampus. Furthermore, BDNF levels are regulated by iron, which is necessary for normal synthesis of neurotransmitters and also for the aromatic hydroxylase enzymes present in neurones. For this reason, the neurobioavailability of iron and the ability of the brain to capture iron from the blood are important for maintaining adequate levels of BDNF and neurotransmitters involved in emotional processes, including depression [142]. The hypothesis that dysfunctions in the glutamatergic system may be associated with the appearance of depression is currently under intensive investigation and is not yet fully confirmed. However, there is evidence that iron deficiency can affect changes in the glutamatergic system and lead to mood disorders. Iron plays an important role as an enzyme cofactor in metabolic reactions that lead to the production and release of the neurotransmitter glutamate [143]. A recent review by Wassef et al. found that anemia and/or iron deficiency may contribute to postpartum depression in women at risk [144]. Richardson et al. showed that higher body iron levels in young adult males may be associated with more depressive symptoms [145].
The role of calcium in the pathophysiology of depression can be explained by its involvement in several mechanisms. One of these is the involvement in the regulation of the hypothalamic–pituitary–adrenal (HPA) system. Furthermore, extracellular calcium influx is an important component of many neuronal processes. Changes in extracellular Ca2+ concentration may be involved in emotion regulation, which may be a direct effect of Ca on stabilisation of the plasma membrane, and NMDA may also affect neuronal plasticity [146]. Table 7 shows, based on the current literature, studies that determined dietary elemental intake and self-reported depression.

4. Limitations

The article delineates the role and significance of nutritional components in the diet within the context of their impact on the nervous system and depressive symptoms. Furthermore, it presents research pertaining to the relationship between the consumption of nutritional components in the diet and their influence on depression. Nevertheless, it has some limitations. One is that it is mainly based on cross-sectional studies, which make it impossible to determine causal conclusions and need to be supplemented and confirmed by longitudinal clinical-control studies. However, it should be noted that observational studies are also a valuable source of information, contributing to the evaluation of the available scientific evidence. The studies included in this review were primarily based on observation of large groups of subjects, allowing more representative and general data. Furthermore, the diagnosis of depression was mainly based on self-report questionnaires, which assess depressive symptoms, but should not be considered equivalent to a clinical diagnosis of depression and therefore would need to be completed according to the DSM criteria. Another limitation is the evaluation of dietary nutrient intake, which was mostly done on the basis of food frequency questionnaires or 24 h interviews, which poses the risk of under or overestimation of data, although in most studies participants were carefully instructed on how to complete the questionnaire or dietary interview (for example, it was conducted twice, one in the presence of the research team person and the other a few days after, by telephone). However, it should be stressed that there is no perfect tool for assessing food intake and that, in most low-cost and simple methods, some limitations are inevitable. Furthermore, when nutrients are consumed together rather than separately, they can influence each other through their interactive or synergistic effects. Therefore, the study of dietary patterns is a second interesting area of research in addition to assessing the impact of individual nutrients.

5. Strengths and Future Research Directions

Given the current state of knowledge and the often contradictory results of studies dedicated to the impact of nutrition on mental health, this review seems to be a needed addition to this information. The number of articles included in this review can be seen as a strength. It is not easy to discuss the effectiveness of introducing nutritional interventions among people with a risk of developing or current psychiatric disorders. It can certainly be argued that the presented data show that nutrition should not be considered as the only means of preventing depression or replacing pharmacology. Additionally, dietary modifications appear to be an underused tool for improving mental health. The development of psychological nutrition faces many obstacles, including the difficulty of maintaining a healthy, varied diet, given the popularity of the Western diet and the difficulty of adhering to dietary recommendations among patients with depression.
This review also aims to spread awareness of nutrition and its impact on mental health and highlight it for further research. Risk groups such as pregnant women, in whom the need for many nutrients increases and the supply of these nutrients from the diet is insufficient, are also very important [161]. The nutrients ingested by pregnant women are essential to facilitate normal growth and development of the foetus, particularly with respect to the maturation of the nervous system [162]. It is recommended that more work should be done to create clear dietary recommendations for the risk and prevalence of mental health problems. This aspect should also be taken into account in supplementation programmes.
It is also worth noting that behavioural factors such as physical inactivity, excessive alcohol consumption and smoking, and sleep deprivation can influence poor eating habits and lead to nutrient deficiencies [163]. For example, people with sleep disorders often have a greater tendency to eat highly processed and nutritionally poor foods, which can lead to nutritional deficiencies [163,164]. In addition, overweight and obesity, often as a consequence of unhealthy lifestyles, are linked to depressive disorders [165]. Alcohol and tobacco can also affect nutrient absorption and metabolism, contributing to deficiencies. These deficiencies can further affect neurochemical balance and brain function, contributing to the development or exacerbation of depressive symptoms [166]. It is worth considering these factors in future research into the role of nutrition in depression and to approach healthy lifestyles in a holistic way, taking into account the various aspects that support mental health [167,168,169,170]. Research that considers these aspects may provide a more comprehensive understanding of the mechanisms through which these factors influence the development and course of depression. This information may be valuable for the development of more effective dietary strategies and interventions to alleviate the symptoms of depression by optimising nutrients and changing unhealthy lifestyle behaviours.

6. Conclusions

Deficiencies in nutrients such as protein, B vitamins, vitamin D, magnesium, zinc, selenium, iron, calcium, and omega-3 fatty acids have a significant impact on the function of the brain and nervous system, which can affect the appearance of depressive symptoms. On the other hand, an excess of certain nutrients in the diet can also have a negative impact on mental health (copper, iron). To prevent deficiencies of the listed nutrients in the diet, it is worth noting the importance of a varied and balanced diet, while also taking into account the potential risks associated with the absorption and bioavailability of certain components through the presence of other components in the diet [171]. In summary, based on the available scientific evidence, a diet that supports mental health should consist mainly of vegetables, fruits, whole grains, sources of vegetable protein, legumes, nuts, fish, low-fat dairy products, while limiting the intake of simple sugars and highly processed foods [172]. The indicated food sources contain vitamins, minerals, tryptophan, fibre, antioxidants, and good quality fats, which can benefit mental health by reducing oxidative stress, inflammation and providing essential nutrients for the brain. However, it is important to remember that diet in itself is not the only factor influencing the risk of or helping to treat depression. There are many other aspects, such as physical activity, sleep, stress management, and social support, that also play an important role in maintaining mental health. It is worth approaching a healthy lifestyle in a comprehensive way, taking into account different aspects to support mental health. Further studies, including prospective cohort, case-control studies, are recommended to draw more reliable conclusions. Table 8 summarizes the effects of the nutrients described on the risk of depressive symptoms.

Author Contributions

Conceptualization, M.Z., K.D. and E.Ł.; data curation, K.D. and M.Z.; methodology, M.Z. and K.D.; resources, E.Ł., K.D. and M.Z.; writing—original draft, M.Z. and K.D.; writing—review and editing, M.Z., E.Ł. and K.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Beurel, E.; Toups, M.; Nemeroff, C. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron 2020, 107, 234–256. [Google Scholar] [CrossRef] [PubMed]
  2. WHO. Adolescent Mental Health. Available online: https://www.who.int/news-room/fact-sheets/detail/depression. (accessed on 13 April 2023).
  3. Ettman, C.; Abdalla, S.; Cohen, G.; Sampson, L.; Vivier, P.; Galea, S. Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2020, 3, e2019686. [Google Scholar] [CrossRef] [PubMed]
  4. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 2022, 9, 137–150. [Google Scholar] [CrossRef] [PubMed]
  5. Institute for Health Metrics and Evaluation. Global Health Data Exchange 2019; University of Washington: Washington, DC, USA, 2019. [Google Scholar]
  6. Remes, O.; Mendes, J.; Templeton, P. Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature. Brain Sci. 2021, 11, 1633. [Google Scholar] [CrossRef]
  7. Salk, R.; Hyde, J.; Abramson, L. Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychol. Bull. 2017, 143, 783–822. [Google Scholar] [CrossRef]
  8. Grundström, J.; Konttinen, H.; Berg, N.; Kiviruusu, O. Associations between relationship status and mental well-being in different life phases from young to middle adulthood. SSM Popul. Health 2021, 14, 100774. [Google Scholar] [CrossRef]
  9. Birk, J.; Kronish, I.; Moise, N.; Falzon, L.; Yoon, S.; Davidson, K. Depression and multimorbidity: Considering temporal characteristics of the associations between depression and multiple chronic diseases. Health Psychol. 2019, 38, 802–811. [Google Scholar] [CrossRef]
  10. Herrera, P.; Campos-Romero, S.; Szabo, W.; Martínez, P.; Guajardo, V.; Rojas, G. Understanding the Relationship between Depression and Chronic Diseases Such as Diabetes and Hypertension: A Grounded Theory Study. Int. J. Environ. Res. Public Health 2021, 18, 12130. [Google Scholar] [CrossRef]
  11. Saraswathy, K.; Ansari, S.; Kaur, G.; Joshi, P.; Chandel, S. Association of vitamin B12 mediated hyperhomocysteinemia with depression and anxiety disorder: A cross-sectional study among Bhil indigenous population of India. Clin. Nutr. ESPEN 2019, 30, 199–203. [Google Scholar] [CrossRef]
  12. Ljungberg, T.; Bondza, E.; Lethin, C. Evidence of the Importance of Dietary Habits Regarding Depressive Symptoms and Depression. Int. J. Environ. Res. Public Health 2020, 17, 1616. [Google Scholar] [CrossRef]
  13. Lasserre, A.; Strippoli, M.; Marques-Vidal, P.; Williams, L.; Jacka, F.N.; Vandeleur, C.; Vollenweider, P.; Preisig, M. Dietary Patterns are Differentially Associated with Atypical and Melancholic Subtypes of Depression. Nutrients 2021, 13, 768. [Google Scholar] [CrossRef] [PubMed]
  14. Pano, O.; Martínez-Lapiscina, E.; Sayón-Orea, C.; Martinez-Gonzalez, M.; Martinez, J.; Sanchez-Villegas, A. Healthy diet, depression and quality of life: A narrative review of biological mechanisms and primary prevention opportunities. World J. Psychiatry 2021, 11, 997–1016. [Google Scholar] [CrossRef]
  15. Natacci, L.; Marchioni, D.; Goulart, A.; Nunes, M.; Moreno, A.; Cardoso, L.; Giatti, L.; Molina, M.; Santos, I.; Brunoni, A.; et al. Omega 3 Consumption and Anxiety Disorders: A Cross-Sectional Analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Nutrients 2018, 10, 663. [Google Scholar] [CrossRef] [PubMed]
  16. Huang, Q.; Liu, H.; Suzuki, K.; Ma, S.; Liu, C. Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression. Antioxidants 2019, 8, 376. [Google Scholar] [CrossRef] [PubMed]
  17. Gartlehner, G.; Wagner, G.; Matyas, N.; Titscher, V.; Greimel, J.; Lux, L.; Gaynes, B.; Viswanathan, M.; Patel, S.; Lohr, K. Pharmacological and non-pharmacological treatments for major depressive disorder: Review of systematic reviews. BMJ Open 2017, 7, e014912. [Google Scholar] [CrossRef]
  18. Blackburn, T. Depressive disorders: Treatment failures and poor prognosis over the last 50 years. Pharm. Res. Perspect. 2019, 7, e00472. [Google Scholar] [CrossRef]
  19. Gabriel, F.; de Melo, D.; Fráguas, R.; Leite-Santos, N.; Mantovani da Silva, R.; Ribeiro, E. Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations. PLoS ONE 2020, 15, e0231700. [Google Scholar] [CrossRef]
  20. Ghaleiha, A.; Davari, H.; Jahangard, L.; Haghighi, M.; Ahmadpanah, M.; Seifrabie, M.; Bajoghli, H.; Holsboer-Trachsler, E.; Brand, S. Adjuvant thiamine improved standard treatment in patients with major depressive disorder: Results from a randomized, double-blind, and placebo-controlled clinical trial. Eur. Arch. Psychiatry Clin. Neurosci. 2016, 266, 695–702. [Google Scholar] [CrossRef]
  21. Halaris, A.; Sohl, E.; Whitham, E. Treatment-Resistant Depression Revisited: A Glimmer of Hope. J. Pers. Med. 2021, 11, 155. [Google Scholar] [CrossRef]
  22. McCarron, R.; Shapiro, B.; Rawles, J.; Luo, J. Depression. Ann. Intern. Med. 2021, 174, ITC65–ITC80. [Google Scholar] [CrossRef]
  23. Ceolin, G.; Breda, V.; Koning, E.; Meyyappan, A.; Gomes, F.; Moreira, J.; Gerchman, F.; Brietzke, E. A Possible Antidepressive Effect of Dietary Interventions: Emergent Findings and Research Challenges. Curr. Treat. Options Psychiatry 2022, 9, 151–162. [Google Scholar] [CrossRef] [PubMed]
  24. O’Neill, S.; Minehan, M.; Knight-Agarwal, C.; Turner, M. Depression, Is It Treatable in Adults Utilising Dietary Interventions? A Systematic Review of Randomised Controlled Trials. Nutrients 2022, 14, 1398. [Google Scholar] [CrossRef]
  25. Nedic Erjavec, G.; Sagud, M.; Nikolac Perkovic, M.; Svob Strac, D.; Konjevod, M.; Tudor, L.; Uzun, S.; Pivac, N. Depression: Biological markers and treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 2021, 105, 110139. [Google Scholar] [CrossRef] [PubMed]
  26. Duman, R.; Sanacora, G.; Krystal, J. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments. Neuron 2019, 102, 75–90. [Google Scholar] [CrossRef]
  27. Belmaker, R.; Agam, G. Major depressive disorder. N. Engl. J. Med. 2008, 358, 55–68. [Google Scholar] [CrossRef] [PubMed]
  28. Pan, J.; Xia, J.; Deng, F.; Liang, W.; Wu, J.; Yin, B.-M.; Dong, M.-X.; Chen, J.-J.; Ye, F.; Wang, H.-Y.; et al. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: A targeted metabolomics study. Transl. Psychiatry 2018, 8, 130. [Google Scholar] [CrossRef] [PubMed]
  29. Teleanu, R.; Niculescu, A.; Roza, E.; Vladâcenco, O.; Grumezescu, A.; Teleanu, D. Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. Int. J. Mol. Sci. 2022, 23, 5954. [Google Scholar] [CrossRef]
  30. Maher, T. Chapter 13—Effects of nutrients on brain function. Prog. Brain Res. 2000, 122, 189–194. [Google Scholar] [CrossRef]
  31. Gómez-Pinilla, F. Brain foods: The effects of nutrients on brain function. Nat. Rev. Neurosci. 2008, 9, 568–578. [Google Scholar] [CrossRef]
  32. Martínez-Cengotitabengoa, M.; González-Pinto, A. Nutritional supplements in depressive disorders. Actas Esp. Psiquiatr. 2017, 45, 8–15. [Google Scholar]
  33. Logan, A.; Jacka, F. Nutritional psychiatry research: An emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch. J. Physiol. Anthropol. 2014, 33, 22. [Google Scholar] [CrossRef] [PubMed]
  34. Jacka, F. Nutritional Psychiatry: Where to Next? EBioMedicine 2017, 17, 24–29. [Google Scholar] [CrossRef] [PubMed]
  35. Hüfner, K.; Giesinger, J.; Gostner, J.; Egeter, J.; Koudouovoh-Tripp, P.; Vill, T.; Fuchs, D.; Sperner-Unterweger, B. Neurotransmitter Precursor Amino Acid Ratios Show Differential, Inverse Correlations with Depression Severity in the Low and High Depression Score Range. Int. J. Tryptophan Res. 2021, 14, 11786469211039220. [Google Scholar] [CrossRef] [PubMed]
  36. Kofler, M.; Schiefecker, A.; Gaasch, M.; Sperner-Unterweger, B.; Fuchs, D.; Beer, R.; Ferger, B.; Rass, V.; Hackl, W.; Rhomberg, P.; et al. A reduced concentration of brain interstitial amino acids is associated with depression in subarachnoid hemorrhage patients. Sci. Rep. 2019, 9, 2811. [Google Scholar] [CrossRef]
  37. Li, D.; Tong, Y.; Li, Y. Associations of dietary trans fatty acid intake with depressive symptoms in midlife women. J. Affect. Disord. 2020, 260, 194–199. [Google Scholar] [CrossRef] [PubMed]
  38. Fernandes, M.; Mutch, D.; Leri, F. The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants. Nutrients 2017, 9, 298. [Google Scholar] [CrossRef] [PubMed]
  39. Clemente-Suárez, V.; Mielgo-Ayuso, J.; Martín-Rodríguez, A.; Ramos-Campo, D.; Redondo-Flórez, L.; Tornero-Aguilera, J.F. The Burden of Carbohydrates in Health and Disease. Nutrients 2022, 14, 3809. [Google Scholar] [CrossRef] [PubMed]
  40. Mantantzis, K.; Schlaghecken, F.; Sünram-Lea, S.; Maylor, E. Sugar rush or sugar crash? A meta-analysis of carbohydrate effects on mood. Neurosci. Biobehav. Rev. 2019, 101, 45–67. [Google Scholar] [CrossRef]
  41. Rahimlou, M.; Morshedzadeh, N.; Karimi, S.; Jafarirad, S. Association between dietary glycemic index and glycemic load with depression: A systematic review. Eur. J. Nutr. 2018, 57, 2333–2340. [Google Scholar] [CrossRef]
  42. Salari-Moghaddam, A.; Saneei, P.; Larijani, B.; Esmaillzadeh, A. Glycemic index, glycemic load, and depression: A systematic review and meta-analysis. Eur. J. Clin. Nutr. 2019, 73, 356–365. [Google Scholar] [CrossRef]
  43. Kohn, J. Is Dietary Fiber Considered an Essential Nutrient? J. Acad. Nutr. Diet. 2016, 116, 360. [Google Scholar] [CrossRef] [PubMed]
  44. Saghafian, F.; Hajishafiee, M.; Rouhani, P.; Saneei, P. Dietary fiber intake, depression, and anxiety: A systematic review and meta-analysis of epidemiologic studies. Nutr. Neurosci. 2023, 26, 108–126. [Google Scholar] [CrossRef] [PubMed]
  45. Zhang, J.; Zhang, N.; Du, S.; He, H.; Xu, Y.; Cai, H.; Guo, X.; Ma, G. The Effects of Hydration Status on Cognitive Performances among Young Adults in Hebei, China: A Randomized Controlled Trial (RCT). Int. J. Environ. Res. Public Health 2018, 15, 1477. [Google Scholar] [CrossRef] [PubMed]
  46. Liska, D.; Mah, E.; Brisbois, T.; Barrios, P.; Baker, L.; Spriet, L. Narrative Review of Hydration and Selected Health Outcomes in the General Population. Nutrients 2019, 11, 70. [Google Scholar] [CrossRef]
  47. Li, Y.; Zhang, C.; Li, S.; Zhang, D. Association between dietary protein intake and the risk of depressive symptoms in adults. Br. J. Nutr. 2020, 123, 1290–1301. [Google Scholar] [CrossRef]
  48. Sheikhi, A.; Siassi, F.; Djazayery, A.; Guilani, B.; Azadbakht, L. Plant and animal protein intake and its association with depression, anxiety, and stress among Iranian women. BMC Public Health 2023, 23, 161. [Google Scholar] [CrossRef]
  49. Suga, H.; Asakura, K.; Kobayashi, S.; Nojima, M.; Sasaki, S. Association between habitual tryptophan intake and depressive symptoms in young and middle-aged women. J. Affect. Disord. 2018, 231, 44–50. [Google Scholar] [CrossRef]
  50. Koochakpoor, G.; Salari-Moghaddam, A.; Keshteli, A.; Afshar, H.; Esmaillzadeh, A.; Adibi, P. Dietary intake of branched-chain amino acids in relation to depression, anxiety and psychological distress. Nutr. J. 2021, 20, 11. [Google Scholar] [CrossRef]
  51. Reuter, M.; Zamoscik, V.; Plieger, T.; Bravo, R.; Ugartemendia, L.; Rodriguez, A.; Kirsch, P. Tryptophan-rich diet is negatively associated with depression and positively linked to social cognition. Nutr. Res. 2021, 85, 14–20. [Google Scholar] [CrossRef]
  52. Wilson, J.; McMullan, I.; Blackburn, N.; Klempel, N.; Yakkundi, A.; Armstrong, N.C.; Armstrong, N.C.; Brolly, C.; Butler, L.T.; Barnett, Y.; et al. Changes in dietary fat intake and associations with mental health in a UK public sample during the COVID-19 pandemic. J. Public Health 2021, 43, 687–694. [Google Scholar] [CrossRef]
  53. Currenti, W.; Godos, J.; Alanazi, A.; Lanza, G.; Ferri, R.; Caraci, F.; Galvano, F.; Castellano, S.; Grosso, G. Dietary Fats and Depressive Symptoms in Italian Adults. Nutrients 2023, 15, 675. [Google Scholar] [CrossRef] [PubMed]
  54. Sanchez-Villegas, A.; Zazpe, I.; Santiago, S.; Perez-Cornago, A.; Martinez-Gonzalez, M.; Lahortiga-Ramos, F. Added sugars and sugar-sweetened beverage consumption, dietary carbohydrate index and depression risk in the Seguimiento Universidad de Navarra (SUN) Project. Br. J. Nutr. 2018, 119, 211–221. [Google Scholar] [CrossRef]
  55. Ebrahimpour-Koujan, S.; Keshteli, A.; Afshar, H.; Esmaillzadeh, A.; Adibi, P. Adherence to low carbohydrate diet and prevalence of psychological disorders in adults. Nutr. J. 2019, 18, 87. [Google Scholar] [CrossRef] [PubMed]
  56. Makhani, S.; Davies, C.; George, K.; Castro, G.; Rodriguez de la Vega, P.; Barengo, N. Carbohydrate-to-Fiber Ratio, a Marker of Dietary Intake, as an Indicator of Depressive Symptoms. Cureus 2021, 13, e17996. [Google Scholar] [CrossRef] [PubMed]
  57. Amirinejad, A.; Darand, M.; Davies, M.; Mazidi, A.; Nadjarzadeh, M.; Mirzaei, M.; Khayyatzadeh, S.S. Higher dietary glycemic load is inversely associated with stress prevalence among Iranian adults. BMC Neurosci. 2022, 23, 28. [Google Scholar] [CrossRef]
  58. Pooyan, S.; Rahimi, M.; Mollahosseini, M.; Khorrami-Nezhad, L.; Nasir, Y.; Maghbooli, Z.; Mirzaei, K. A High-Protein/Low-Fat Diet May Interact with Vitamin D-Binding Protein Gene Variants to Moderate the Risk of Depression in Apparently Healthy Adults. Lifestyle Genom. 2018, 11, 64–72. [Google Scholar] [CrossRef]
  59. Oh, J.; Yun, K.; Chae, J.; Kim, T. Association Between Macronutrients Intake and Depression in the United States and South Korea. Front. Psychiatry 2020, 11, 207. [Google Scholar] [CrossRef]
  60. Eissenstat, S.; Gao, N.; Radler, D.; Oh, T. Nutrient Intake Differences Among Ethnic Groups and Risks of Depression. J. Immigr. Minor. Health 2020, 22, 1141–1148. [Google Scholar] [CrossRef]
  61. Lee, S.; Lee, K.; Cho, M. Association of Food Insecurity with Nutrient Intake and Depression among Korean and US Adults: Data from the 2014 Korea and the 2013-2014 US National Health and Nutrition Examination Surveys. Int. J. Environ. Res. Public Health 2021, 18, 506. [Google Scholar] [CrossRef]
  62. Haghighatdoost, F.; Feizi, A.; Esmaillzadeh, A.; Rashidi-Pourfard, N.; Keshteli, A.; Roohafza, H.; Adibi, P. Drinking plain water is associated with decreased risk of depression and anxiety in adults: Results from a large cross-sectional study. World J. Psychiatry 2018, 8, 88–96. [Google Scholar] [CrossRef]
  63. Lange, K. Omega-3 fatty acids and mental health. Glob. Health J. 2020, 4, 18–30. [Google Scholar] [CrossRef]
  64. Healy-Stoffel, M.; Levant, B. N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders. CNS Neurol. Disord Drug Targets 2018, 17, 216–232. [Google Scholar] [CrossRef] [PubMed]
  65. Bazinet, R.; Layé, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014, 15, 771–785. [Google Scholar] [CrossRef] [PubMed]
  66. Zhou, L.; Xiong, J.; Chai, Y.; Huang, L.; Tang, Z.; Zhang, X.; Liu, B.; Zhang, J. Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. Front. Psychiatry 2022, 13, 933704. [Google Scholar] [CrossRef]
  67. Dyall, S. Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA. Front. Aging Neurosci. 2015, 7, 52. [Google Scholar] [CrossRef]
  68. Du, J.; Zhu, M.; Bao, H.; Li, B.; Dong, Y.; Xiao, C.; Zhang, G.; Henter, I.; Rudorfer, M.; Vitiello, B. The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors. Crit. Rev. Food Sci. Nutr. 2016, 56, 2560–2578. [Google Scholar] [CrossRef]
  69. Kalkman, H.; Hersberger, M.; Walitza, S.; Berger, G. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. Int. J. Mol. Sci. 2021, 22, 4393. [Google Scholar] [CrossRef]
  70. Sánchez-Villegas, A.; Álvarez-Pérez, J.; Toledo, E.; Salas-Salvadó, J.; Ortega-Azorín, C.; Zomeño, M.D.; Vioque, J.; Martínez, J.A.; Romaguera, D.; Pérez-López, J.; et al. Seafood Consumption, Omega-3 Fatty Acids Intake, and Life-Time Prevalence of Depression in the PREDIMED-Plus Trial. Nutrients 2018, 10, 2000. [Google Scholar] [CrossRef]
  71. Park, S.; Lee, D.; Kim, B.; Na, K.; Lee, C.; Son, Y.; Lee, H. The Association between Omega-3 Fatty Acid Intake and Human Brain Connectivity in Middle-Aged Depressed Women. Nutrients 2020, 12, 2191. [Google Scholar] [CrossRef]
  72. Zhang, R.; Sun, J.; Li, Y.; Zhang, D. Associations of n-3, n-6 Fatty Acids Intakes and n-6:n-3 Ratio with the Risk of Depressive Symptoms: NHANES 2009-2016. Nutrients 2020, 12, 240. [Google Scholar] [CrossRef]
  73. Li, D.; Liang, H.; Tong, Y.; Li, Y. Association of dietary n-3 polyunsaturated fatty acids intake with depressive symptoms in midlife women. J. Affect. Disord. 2020, 261, 164–171. [Google Scholar] [CrossRef] [PubMed]
  74. Berger, M.; Taylor, S.; Harriss, L.; Campbell, S.; Thompson, F.; Jones, S.; Makrides, M.; Gibson, R.; Paul Amminger, G.; Sarnyai, Z.; et al. Cross-sectional association of seafood consumption, polyunsaturated fatty acids and depressive symptoms in two Torres Strait communities. Nutr. Neurosci. 2020, 23, 353–362. [Google Scholar] [CrossRef] [PubMed]
  75. Chaves, R.; Aguiar, O.; Moreno, A.; Brunoni, A.; Molina, M.; Viana, M.; Bensoñor, I.; Griep, R.; da Fonseca, M. Consumption of Omega-3 and Maintenance and Incidence of Depressive Episodes: The ELSA-Brasil Study. Nutrients 2022, 14, 3227. [Google Scholar] [CrossRef] [PubMed]
  76. Rao, T.; Asha, M.; Ramesh, B.; Rao, K. Understanding nutrition, depression and mental illnesses. Indian J. Psychiatry 2008, 50, 77–82. [Google Scholar] [CrossRef] [PubMed]
  77. Mikkelsen, K.; Stojanovska, L.; Apostolopoulos, V. The Effects of Vitamin B in Depression. Curr. Med. Chem. 2016, 23, 4317–4337. [Google Scholar] [CrossRef] [PubMed]
  78. Wu, Y.; Zhang, L.; Li, S.; Zhang, D. Associations of dietary vitamin B1, vitamin B2, vitamin B6, and vitamin B12 with the risk of depression: A systematic review and meta-analysis. Nutr. Rev. 2022, 80, 351–366. [Google Scholar] [CrossRef]
  79. Papakostas, G.; Ionescu, D. Towards new mechanisms: An update on therapeutics for treatment-resistant major depressive disorder. Mol. Psychiatry 2015, 20, 1142–1150. [Google Scholar] [CrossRef]
  80. Coppen, A.; Bolander-Gouaille, C. Treatment of depression: Time to consider folic acid and vitamin B12. J. Psychopharmacol. 2005, 19, 59–65. [Google Scholar] [CrossRef]
  81. Cordaro, M.; Siracusa, R.; Fusco, R.; Cuzzocrea, S.; Di Paola, R.; Impellizzeri, D. Involvements of Hyperhomocysteinemia in Neurological Disorders. Metabolites 2021, 11, 37. [Google Scholar] [CrossRef]
  82. Kate, N.; Grover, S.; Agarwal, M. Does B12 deficiency lead to lack of treatment response to conventional antidepressants? Psychiatry 2010, 7, 42–44. [Google Scholar]
  83. Berkins, S.; Schiöth, H.; Rukh, G. Depression and Vegetarians: Association between Dietary Vitamin B6, B12 and Folate Intake and Global and Subcortical Brain Volumes. Nutrients 2021, 13, 1790. [Google Scholar] [CrossRef] [PubMed]
  84. Calderón-Ospina, C.; Nava-Mesa, M. B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci. Ther. 2020, 26, 5–13. [Google Scholar] [CrossRef] [PubMed]
  85. Oudman, E. Wernicke encephalopathy in patients with depression: A systematic review. Psychiatry Clin. Neurosci. 2020, 74, 569–572. [Google Scholar] [CrossRef]
  86. Parra, M.; Stahl, S.; Hellmann, H. Vitamin B6 and Its Role in Cell Metabolism and Physiology. Cells 2018, 7, 84. [Google Scholar] [CrossRef] [PubMed]
  87. Wendołowicz, A.; Stefańska, E.; Ostrowska, L. Influence of selected dietary components on the functioning of the human nervous system. Rocz. Panstw. Zakl. Hig. 2018, 69, 15–21. [Google Scholar] [PubMed]
  88. Arévalo, S.; Scott, T.; Falcón, L.; Tucker, K. Vitamin B-6 and depressive symptomatology, over time, in older Latino adults. Nutr Neurosci. 2019, 22, 625–636. [Google Scholar] [CrossRef]
  89. Ekinci, G.; Sanlier, N. The relationship between nutrition and depression in the life process: A mini-review. Exp. Gerontol. 2023, 172, 112072. [Google Scholar] [CrossRef]
  90. Avalos, L.; Nance, N.; Caan, B.; Sujan, A.; Uriu-Adams, J.; Li, D.; Quesenberry, C.; Hedderson, M. Association of serum folate levels during pregnancy and prenatal depression. J. Matern. Neonatal. Med. 2023, 36, 1–4. [Google Scholar] [CrossRef]
  91. Dhiman, P.; Pillai, R.; Wilson, A.; Premkumar, N.; Bharadwaj, B.; Ranjan, V.; Rajendiran, S. Cross-sectional association between vitamin B12 status and probable postpartum depression in Indian women. BMC Pregnancy Childbirth 2021, 21, 146. [Google Scholar] [CrossRef]
  92. Pastore, A.; Martinelli, D.; Piemonte, F.; Tozzi, G.; Boenzi, S.; Di Giovamberardino, G.; Petrillo, S.; Bertini, E.; Dionisi-Vici, C. Glutathione metabolism in cobalamin deficiency type C (cblC). J. Inherit. Metab. Dis. 2014, 37, 125–129. [Google Scholar] [CrossRef]
  93. Ortí, J.; Cuerda-Ballester, M.; Drehmer, E.; Carrera-Juliá, S.; Motos-Muñoz, M.; Cunha-Pérez, C.; Benlloch, M.; López-Rodríguez, M. Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study. Nutrients 2020, 12, 2655. [Google Scholar] [CrossRef] [PubMed]
  94. Wong, C. Vitamin B12 deficiency in the elderly: Is it worth screening? Hong Kong Med. J. 2015, 21, 155–164. [Google Scholar] [CrossRef] [PubMed]
  95. Rizzo, G.; Laganà, A.; Rapisarda, A.; La Ferrera, G.; Buscema, M.; Rossetti, P.; Nigro, A.; Muscia, V.; Valenti, G.; Sapia, F.; et al. Vitamin B12 among Vegetarians: Status, Assessment and Supplementation. Nutrients 2016, 8, 767. [Google Scholar] [CrossRef] [PubMed]
  96. Cavalcoli, F.; Zilli, A.; Conte, D.; Massironi, S. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review. World J. Gastroenterol. 2017, 23, 563–572. [Google Scholar] [CrossRef] [PubMed]
  97. Duc, H.; Oh, H.; Yoon, I.; Kim, M. Association between levels of thiamine intake, diabetes, cardiovascular diseases and depression in Korea: A national cross-sectional study. J. Nutr. Sci. 2021, 10, e31. [Google Scholar] [CrossRef]
  98. Nguyen, H.; Oh, H.; Hoang, N.; Jo, W.; Kim, M. Environmental science and pollution research role of heavy metal concentrations and vitamin intake from food in depression: A national cross-sectional study (2009–2017). Environ. Sci. Pollut. Res. Int. 2022, 29, 4574–4586. [Google Scholar] [CrossRef]
  99. Kafeshani, M.; Feizi, A.; Esmaillzadeh, A.; Keshteli, A.; Afshar, H.; Roohafza, H.; Adibi, P. Higher vitamin B6 intake is associated with lower depression and anxiety risk in women but not in men: A large cross-sectional study. Int. J. Vitam. Nutr. Res. 2020, 90, 484–492. [Google Scholar] [CrossRef]
  100. Odai, T.; Terauchi, M.; Suzuki, R.; Kato, K.; Hirose, A.; Miyasaka, N. Depressive Symptoms in Middle-Aged and Elderly Women Are Associated with a Low Intake of Vitamin B6: A Cross-Sectional Study. Nutrients 2020, 12, 3437. [Google Scholar] [CrossRef]
  101. Khosravi, M.; Sotoudeh, G.; Amini, M.; Raisi, F.; Mansoori, A.; Hosseinzadeh, M. The relationship between dietary patterns and depression mediated by serum levels of Folate and vitamin B12. BMC Psychiatry 2020, 20, 63. [Google Scholar] [CrossRef]
  102. Zheng, L.; Yu, X.; Jiang, W.; Zhang, D. Total folate, natural folate and synthetic folic acid intake associations with adult depressive symptoms. Asia Pac. J. Clin. Nutr. 2020, 29, 846–855. [Google Scholar] [CrossRef]
  103. Mahdavifar, B.; Hosseinzadeh, M.; Salehi-Abargouei, A.; Mirzaei, M.; Vafa, M. Dietary intake of B vitamins and their association with depression, anxiety, and stress symptoms: A cross-sectional, population-based survey. J. Affect. Disord. 2021, 288, 92–98. [Google Scholar] [CrossRef] [PubMed]
  104. Milaneschi, Y.; Hoogendijk, W.; Lips, P.; Heijboer, A.; Schoevers, R.; van Hemert, A.; Beekman, A.; Smit, J.; Penninx, B. The association between low vitamin D and depressive disorders. Mol. Psychiatry 2014, 19, 444–451. [Google Scholar] [CrossRef] [PubMed]
  105. Andrade, J.; Grandoff, P.; Schneider, S. Vitamin D Intake and Factors Associated with Self-Reported Vitamin D Deficiency Among US Adults: A 2021 Cross-Sectional Study. Front. Nutr. 2022, 9, 899300. [Google Scholar] [CrossRef] [PubMed]
  106. Fipps, D.; Rainey, E. Psychotic Features Abated with Vitamin D Treatment in a Patient with Major Depressive Disorder. Case Rep. Psychiatry 2020, 2020, 2046403. [Google Scholar] [CrossRef] [PubMed]
  107. Lardner, A. Vitamin D and hippocampal development-the story so far. Front. Mol. Neurosci. 2015, 8, 58. [Google Scholar] [CrossRef]
  108. Geng, C.; Shaikh, A.; Han, W.; Chen, D.; Guo, Y.; Jiang, P. Vitamin D and depression: Mechanisms, determination and application. Asia Pac. J. Clin. Nutr. 2019, 28, 689–694. [Google Scholar] [CrossRef]
  109. Muthuramalingam, A.; Menon, V.; Rajkumar, R.; Negi, V. Is Depression an Inflammatory Disease? Findings from a Cross-Sectional Study at a Tertiary Care Center. Indian J. Psychol. Med. 2016, 38, 114–119. [Google Scholar] [CrossRef]
  110. Zhu, D.; Zhao, W.; Zhang, B.; Zhang, Y.; Yang, Y.; Zhang, C.; Wang, Y.; Zhu, J.; Yu, Y. The Relationship Between Serum Concentration of Vitamin D, Total Intracranial Volume, and Severity of Depressive Symptoms in Patients with Major Depressive Disorder. Front. Psychiatry 2019, 10, 322. [Google Scholar] [CrossRef]
  111. Dana-Alamdari, L.; Kheirouri, S.; Noorazar, S. Serum 25-Hydroxyvitamin D in Patients with Major Depressive Disorder. Iran. J. Public Health 2015, 44, 690–697. [Google Scholar]
  112. Berridge, M. Vitamin D and Depression: Cellular and Regulatory Mechanisms. Pharmacol. Rev. 2017, 69, 80–92. [Google Scholar] [CrossRef]
  113. Huiberts, L.; Karin, H. Effects of vitamin D on mood and sleep in the healthy population: Interpretations from the serotonergic pathway. Sleep Med. Rev. 2021, 55, 101379. [Google Scholar] [CrossRef] [PubMed]
  114. Daubner, S.; Le, T.; Wang, S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem. Biophys 2011, 508, 1–12. [Google Scholar] [CrossRef]
  115. Cuomo, A.; Maina, G.; Bolognesi, S.; Rosso, G.; Beccarini Crescenzi, B.; Zanobini, F.; Goracci, A.; Facchi, E.; Favaretto, E.; Baldini, I.; et al. Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients with Mental Illness. Front. Psychiatry 2019, 10, 167. [Google Scholar] [CrossRef] [PubMed]
  116. Tsunoda, K.; Hamazaki, K.; Matsumura, H.; Kasamatsu, A.; Tsuchida, H.; Inadera, H. Dietary Intake of Vitamin D during Pregnancy and the Risk of Postpartum Depressive Symptoms: The Japan Environment and Children’s Study. J. Nutr. Sci. Vitaminol. 2023, 69, 14–20. [Google Scholar] [CrossRef] [PubMed]
  117. Ceolin, G.; Mano, G.; Hames, N.; Antunes, L.; Brietzke, E.; Rieger, D.; Moreira, J. Vitamin D, Depressive Symptoms, and COVID-19 Pandemic. Front. Neurosci. 2021, 15, 670879. [Google Scholar] [CrossRef]
  118. Jahrami, H.; Bragazzi, N.; Grant, W.; AlFarra, H.; AlFara, W.; Mashalla, S.; Saif, Z. Vitamin D Doses from Solar Ultraviolet and Dietary Intakes in Patients with Depression: Results of a Case-Control Study. Nutrients 2020, 12, 2587. [Google Scholar] [CrossRef] [PubMed]
  119. Sajjadi, S.; Foshati, S.; Haddadian-Khouzani, S.; Rouhani, M. The role of selenium in depression: A systematic review and meta-analysis of human observational and interventional studies. Sci. Rep. 2022, 12, 1045. [Google Scholar] [CrossRef]
  120. Szewczyk, B.; Szopa, A.; Serefko, A.; Poleszak, E.; Nowak, G. The role of magnesium and zinc in depression: Similarities and differences. Magnes. Res. 2018, 31, 78–89. [Google Scholar] [CrossRef]
  121. Mlyniec, K. Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression. Curr. Neuropharmacol. 2021, 19, 2012–2019. [Google Scholar] [CrossRef]
  122. Redlich, R.; Opel, N.; Bürger, C.; Dohm, K.; Grotegerd, D.; Förster, K.; Zaremba, D.; Meinert, S.; Repple, J.; Enneking, V.; et al. The Limbic System in Youth Depression: Brain Structural and Functional Alterations in Adolescent In-patients with Severe Depression. Neuropsychopharmacology 2018, 43, 546–554. [Google Scholar] [CrossRef]
  123. Pickering, G.; Mazur, A.; Trousselard, M.; Bienkowski, P.; Yaltsewa, N.; Amessou, M.; Noah, L.; Pouteau, E. Magnesium Status and Stress: The Vicious Circle Concept Revisited. Nutrients 2020, 12, 3672. [Google Scholar] [CrossRef] [PubMed]
  124. Eby, G.A., 3rd; Eby, K.L. Magnesium for treatment-resistant depression: A review and hypothesis. Med. Hypotheses 2010, 74, 649–660. [Google Scholar] [CrossRef] [PubMed]
  125. Ranjbar, E.; Shams, J.; Sabetkasaei, M.; M-Shirazi, M.; Rashidkhani, B.; Mostafavi, A.; Bornak, E.; Nasrollahzadeh, J. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr. Neurosci. 2014, 17, 65–71. [Google Scholar] [CrossRef] [PubMed]
  126. Wang, J.; Um, P.; Dickerman, B.; Liu, J. Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications. Nutrients 2018, 10, 584. [Google Scholar] [CrossRef]
  127. Paoletti, P.; Vergnano, A.; Barbour, B.; Casado, M. Zinc at glutamatergic synapses. Neuroscience 2009, 158, 126–136. [Google Scholar] [CrossRef] [PubMed]
  128. Solati, Z.; Jazayeri, S.; Tehrani-Doost, M.; Mahmoodianfard, S.; Gohari, M. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial. Nutr. Neurosci. 2015, 18, 162–168. [Google Scholar] [CrossRef]
  129. Doboszewska, U.; Wlaź, P.; Nowak, G.; Radziwoń-Zaleska, M.; Cui, R.; Młyniec, K. Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. Neural. Plast. 2017, 2017, 3682752. [Google Scholar] [CrossRef]
  130. Yosaee, S.; Clark, C.; Keshtkaran, Z.; Ashourpour, M.; Keshani, P.; Soltani, S. Zinc in depression: From development to treatment: A comparative/ dose response meta-analysis of observational studies and randomized controlled trials. Gen. Hosp. Psychiatry 2022, 74, 110–117. [Google Scholar] [CrossRef]
  131. Czaderny, K. Risk factors for depression. New evidence on selenium deficiency and depressive disorders. Psychiatr. Pol. 2020, 54, 1109–1121, (In English, In Polish). [Google Scholar] [CrossRef]
  132. Rayman, M. The importance of selenium to human health. Lancet 2000, 356, 233–241. [Google Scholar] [CrossRef]
  133. Santos, A.; Passos, A.; Holzbach, L.; Cardoso, B.; Santos, M.; Coelho, A.; Cominetti, C.; Almeida, G. Lack of sufficient evidence to support a positive role of selenium status in depression: A systematic review. Nutr. Rev. 2022, nuac095. [Google Scholar] [CrossRef] [PubMed]
  134. Hongrong, W.; Qingqi, L.; Rong, G.; Shuangyang, T.; Kaifang, Z.; Jianfeng, Z. BMI Modifies the Association Between Depression Symptoms and Serum Copper Levels. Biol. Trace Elem. Res. 2022. [Google Scholar] [CrossRef] [PubMed]
  135. Ni, M.; You, Y.; Chen, J.; Zhang, L. Copper in depressive disorder: A systematic review and meta-analysis of observational studies. Psychiatry Res. 2018, 267, 506–515. [Google Scholar] [CrossRef]
  136. Słupski, J.; Cubała, W.; Górska, M.; Gałuszko-Węgielnik, M.; Wiglusz, M. Role of copper in depression. Relationship with ketamine treatment. Med. Hypotheses 2018, 119, 14–17. [Google Scholar] [CrossRef] [PubMed]
  137. Naletova, I.; Satriano, C.; Pietropaolo, A.; Gianì, F.; Pandini, G.; Triaca, G.; Amadoro, V.; Latina, P.; Calissano, A.; Travaglia, V.; et al. The Copper(II)-Assisted Connection between NGF and BDNF by Means of Nerve Growth Factor-Mimicking Short Peptides. Cells 2019, 8, 301. [Google Scholar] [CrossRef] [PubMed]
  138. La Mendola, D. Nerve growth factor catches copper in neuronal inning. Neural. Regen. Res. 2020, 15, 665–666. [Google Scholar] [CrossRef]
  139. Crayton, J.; Walsh, W. Elevated serum copper levels in women with a history of post-partum depression. J. Trace Elem. Med. Biol. 2007, 21, 17–21. [Google Scholar] [CrossRef]
  140. Scheiber, I.; Mercer, J.; Dringen, R. Metabolism and functions of copper in brain. Prog. Neurobiol. 2014, 116, 33–57. [Google Scholar] [CrossRef]
  141. Lee, H.; Chao, H.; Huang, W.; Chen, S.; Yang, H. Psychiatric disorders risk in patients with iron deficiency anemia and association with iron supplementation medications: A nationwide database analysis. BMC Psychiatry 2020, 20, 216. [Google Scholar] [CrossRef]
  142. Berthou, C.; Iliou, J.; Barba, D. Iron, neuro-bioavailability and depression. EJHaem 2021, 3, 263–275. [Google Scholar] [CrossRef]
  143. McGahan, M.; Harned, J.; Mukunnemkeril, M.; Goralska, M.; Fleisher, L.; Ferrell, J. Iron alters glutamate secretion by regulating cytosolic aconitase activity. Am. J. Physiol. Cell Physiol. 2005, 288, C1117–C1124. [Google Scholar] [CrossRef] [PubMed]
  144. Wassef, A.; Nguyen, Q.; St-André, M. Anaemia and depletion of iron stores as risk factors for postpartum depression: A literature review. J. Psychosom. Obstet. Gynaecol. 2019, 40, 19–28. [Google Scholar] [CrossRef] [PubMed]
  145. Richardson, A.; Heath, A.; Haszard, J.; Polak, M.; Houghton, L.; Conner, T. Higher Body Iron Is Associated with Greater Depression Symptoms among Young Adult Men but not Women: Observational Data from the Daily Life Study. Nutrients 2015, 7, 6055–6072. [Google Scholar] [CrossRef] [PubMed]
  146. Mikulska, J.; Juszczyk, G.; Gawrońska-Grzywacz, M.; Herbet, M. HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation. Brain Sci. 2021, 11, 1298. [Google Scholar] [CrossRef] [PubMed]
  147. Anjom-Shoae, J.; Sadeghi, O.; Hassanzadeh Keshteli, A.; Afshar, H.; Esmaillzadeh, A.; Adibi, P. The association between dietary intake of magnesium and psychiatric disorders among Iranian adults: A cross-sectional study. Br. J. Nutr. 2018, 120, 693–702. [Google Scholar] [CrossRef] [PubMed]
  148. Sun, C.; Wang, R.; Li, Z.; Zhang, D. Dietary magnesium intake and risk of depression. J. Affect. Disord. 2019, 246, 627–632. [Google Scholar] [CrossRef] [PubMed]
  149. Chou, M.; Yang, Y.; Wang, J.; Lin, C.; Lin, S. The Association of Serum and Dietary Magnesium with Depressive Symptoms. Nutrients 2023, 15, 774. [Google Scholar] [CrossRef] [PubMed]
  150. Hajianfar, H.; Mollaghasemi, N.; Tavakoly, R.; Campbell, M.; Mohtashamrad, M.; Arab, A. The Association Between Dietary Zinc Intake and Health Status, Including Mental Health and Sleep Quality, Among Iranian Female Students. Biol. Trace Elem. Res. 2021, 199, 1754–1761. [Google Scholar] [CrossRef]
  151. Hu, B.; Lin, Z.; Zou, R.; Gan, Y.; Ji, J.; Guo, J.; Li, W.; Guo, Y.; Xu, H.; Sun, D.; et al. Dietary Zinc Intake Affects the Association Between Dietary Vitamin A and Depression: A Cross-Sectional Study. Front. Nutr. 2022, 9, 913132. [Google Scholar] [CrossRef]
  152. Ghimire, S.; Baral, B.K.; Feng, D.; Sy, F.S.; Rodriguez, R. Is selenium intake associated with the presence of depressive symptoms among US adults? Findings from National Health and Nutrition Examination Survey (NHANES) 2011–2014. Nutrition 2019, 62, 169–176. [Google Scholar] [CrossRef]
  153. Ferreira de Almeida, T.L.; Petarli, G.B.; Cattafesta, M.; Zandonade, E.; Bezerra, O.M.P.A.; Tristão, K.G.; Salaroli, L.B. Association of Selenium Intake and Development of Depression in Brazilian Farmers. Front. Nutr. 2021, 8, 671377. [Google Scholar] [CrossRef] [PubMed]
  154. Nakamura, M.; Miura, A.; Nagahata, T.; Shibata, Y.; Okada, E.; Ojima, T. Low Zinc, Copper, and Manganese Intake is Associated with Depression and Anxiety Symptoms in the Japanese Working Population: Findings from the Eating Habit and Well-Being Study. Nutrients 2019, 11, 847. [Google Scholar] [CrossRef] [PubMed]
  155. Li, Z.; Wang, W.; Xin, X.; Song, X.; Zhang, D. Association of total zinc, iron, copper and selenium intakes with depression in the US adults. J. Affect. Disord. 2018, 228, 68–74. [Google Scholar] [CrossRef] [PubMed]
  156. Shen, X.; Gu, X.; Liu, Y.; Yang, L.; Zheng, M.; Jiang, L. Association between dietary calcium and depression among American adults: National health and nutrition examination survey. Front. Nutr. 2023, 10, 1042522. [Google Scholar] [CrossRef] [PubMed]
  157. Sánchez-Villegas, A.; Pérez-Cornago, A.; Zazpe, I.; Santiago, S.; Lahortiga, F.; Martínez-González, M. Micronutrient intake adequacy and depression risk in the SUN cohort study. Eur. J. Nutr. 2018, 57, 2409–2419. [Google Scholar] [CrossRef] [PubMed]
  158. Salehi-Abargouei, A.; Esmaillzadeh, A.; Azadbakht, L.; Keshteli, A.; Afshar, H.; Feizi, A.; Feinle-Bisset, C.; Adibi, P. Do patterns of nutrient intake predict self-reported anxiety, depression and psychological distress in adults? SEPAHAN study. Clin. Nutr. 2019, 38, 940–947. [Google Scholar] [CrossRef]
  159. Yun, H.; Kim, D.; Lee, E.; Jung, J.; Yoo, S. Analysis of the Effects of Nutrient Intake and Dietary Habits on Depression in Korean Adults. Nutrients 2021, 13, 1360. [Google Scholar] [CrossRef]
  160. Ferriani, L.; Silva, D.; Molina, M.; Mill, J.; Brunoni, A.; da Fonseca, M.; Moreno, A.; Benseñor, I.; de Aguiar, O.; Barreto, S.; et al. Associations of depression and intake of antioxidants and vitamin B complex: Results of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J. Affect. Disord. 2022, 297, 259–268. [Google Scholar] [CrossRef]
  161. Cortés-Albornoz, M.; García-Guáqueta, D.; Velez-van-Meerbeke, A.; Talero-Gutiérrez, C. Maternal Nutrition and Neurodevelopment: A Scoping Review. Nutrients 2021, 13, 3530. [Google Scholar] [CrossRef]
  162. Heland, S.; Fields, N.; Ellery, S.; Fahey, M.; Palmer, K. The role of nutrients in human neurodevelopment and their potential to prevent neurodevelopmental adversity. Front. Nutr. 2022, 9, 992120. [Google Scholar] [CrossRef]
  163. Chaput, J.P. Sleep patterns, diet quality and energy balance. Physiol. Behav. 2014, 134, 86–91. [Google Scholar] [CrossRef] [PubMed]
  164. Oftedal, S.; Vandelanotte, C.; Duncan, M.J. Patterns of Diet, Physical Activity, Sitting and Sleep Are Associated with Socio-Demographic, Behavioural, and Health-Risk Indicators in Adults. Int. J. Environ. Res. Public Health 2019, 16, 2375. [Google Scholar] [CrossRef] [PubMed]
  165. Pereira-Miranda, E.; Costa, P.R.F.; Queiroz, V.A.O.; Pereira-Santos, M.; Santana, M.L.P. Overweight and Obesity Associated with Higher Depression Prevalence in Adults: A Systematic Review and Meta-Analysis. J. Am. Coll. Nutr. 2017, 36, 223–233. [Google Scholar] [CrossRef] [PubMed]
  166. Padrão, P.; Lunet, N.; Santos, A.C.; Barros, H. Smoking, alcohol, and dietary choices: Evidence from the Portuguese National Health Survey. BMC Public Health 2007, 7, 138. [Google Scholar] [CrossRef]
  167. Schuch, F.B.; Vancampfort, D. Physical activity, exercise, and mental disorders: It is time to move on. Trends Psychiatry Psychother. 2021, 43, 177–184. [Google Scholar] [CrossRef] [PubMed]
  168. Mahindru, A.; Patil, P.; Agrawal, V. Role of Physical Activity on Mental Health and Well-Being: A Review. Cureus 2023, 15, e33475. [Google Scholar] [CrossRef]
  169. Kunugi, H. Depression and lifestyle: Focusing on nutrition, exercise, and their possible relevance to molecular mechanisms. Psychiatry Clin. Neurosci. 2023. online. [Google Scholar] [CrossRef]
  170. Cui, N.; Cui, J.; Xu, X.; Aslam, B.; Bai, L.; Li, D.; Wu, D.; Ma, Z.; Sun, J.; Baloch, Z. Health Conditions, Lifestyle Factors and Depression in Adults in Qingdao, China: A Cross-Sectional Study. Front. Psychiatry 2021, 12, 508810. [Google Scholar] [CrossRef]
  171. Arredondo, M.; Martínez, R.; Núñez, M.; Ruz, M.; Olivares, M. Inhibition of iron and copper uptake by iron, copper and zinc. Biol. Res. 2006, 39, 95–102. [Google Scholar] [CrossRef]
  172. Cena, H.; Calder, P.C. Defining a Healthy Diet: Evidence for The Role of Contemporary Dietary Patterns in Health and Disease. Nutrients 2020, 12, 334. [Google Scholar] [CrossRef]
Table 1. Eligibility criteria.
Table 1. Eligibility criteria.
Inclusion CriteriaExclusion Criteria
-
Studies involving adults (people aged >18 years).
-
Observational studies (including cohort, longitudinal, and cross-sectional studies) and interventional studies (randomised controlled clinical trials).
-
Studies that focused on assessing dietary nutrient deficiencies.
-
The main focus was on major depressive disorder (MDD).
-
Papers were included regardless of the measurement methods used in the study (mainly self-reporting tools or medical diagnosis).
-
Articles published in English.
-
Studies published in the last five years (between 2018 and 2023).
-
Animal studies, reviews, case reports, editorials.
-
Studies assessing depression as a secondary disease to another disorder and cancer.
-
Studies that assess depression in the context of nutrition after bariatric surgery.
-
Research only in paediatric and elderly populations and pregnant and/or breastfeeding women, as these are populations that would require a separate, stand-alone study on the topic described.
-
Studies that focused exclusively on evaluating the effectiveness of dietary interventions (for example, Western diet, Mediterranean diet, and others) or exclusively on nutrient supplementation.
-
Research that exclusively focusses on bipolar disorder.
-
Studies exclusively on depression and the gut–brain axis.
-
Articles published in a language other than English.
-
Studies published before 2018.
Table 2. Relationship between dietary macronutrients and water intake and the risk of depressive symptoms.
Table 2. Relationship between dietary macronutrients and water intake and the risk of depressive symptoms.
AuthorsYear of PublicationType of StudyThe GroupAssessment of Depression and Dietary IntakeResults and Conclusions
Proteins
Li et al. [47] 2020National cross-sectional surveyn = 17,845 adultsPatient Health Questionnaire-9 (PHQ-9) and two 24 h dietary recall interviewsTotal protein intake and protein intake from milk and dairy products may reduce the risk of depressive symptoms in American adults, but not for protein intake from red meat, poultry, fish, cereals, and legumes.
Sheikhi et al. [48] 2023Cross-sectional studyn = 489 Iranian womenDepression, Anxiety, and Stress Scales (DASS) questionnaire and Semi-quantitative Food Frequency QuestionnaireWomen were more likely to show symptoms of depression in the highest tertile of animal protein intake. A diet high in animal protein may predispose to mental illness.
Amino acids
Suga et al. [49] 2018Cross-sectional studyn = 7923 adultsCenter for Epidemiologic Studies Depression Scale (CES-D) and validated, self-administered diet history questionnaireWomen with depression consumed more energy and less tryptophan than women without depression.
Tryptophan intake was inversely associated with depressive symptoms in young adult women.
Koochakpoor et al. [50] 2021Cross-sectional studyn = 3175 adultsHospital Anxiety and Depression Scale (HADS) and Food Frequency Questionnaire (FFQ)Subjects in the study with the highest total branched-chain amino acid (BCAA) tercile intake had a lower risk of depression.
There was also a significant inverse relationship observed between isoleucine intake and the likelihood of depression.
Reuter et al. [51] 2021Cross-sectional studyn = 482 adultsBeck Depression Inventory-II (BDI-II) and participants were asked for their general consumption of TRP-rich foodsA diet rich in tryptophan has been shown to have a positive effect on mood. High amounts of tryptophan in the diet appear to protect against depression and have a positive effect on social interactions.
Fats
Wilson et al. [52] 2021Cross-sectional studyn = 887 adultsBeck Depression Inventory-II (BDI-II) and Dietary Instrument for Nutrition Education questionnaire (DINE) No relationship was observed between the amount of fat ingested in the diet and mental health.
Currenti et al. [53] 2023Cross-sectional studyn = 1572 adults Center for the Epidemiological Studies of Depression Short Form (CES-D and two Food Frequency Questionnaires (FFQs; a long and a short version)No association was found between total fat intake and depressive symptoms.
Carbohydrates
Sanchez-Villegas et al. [54] 2018Prospective cohort studyn = 15,546 adultsFollow-up questionnaire and diagnosis of depression using a clinical interview for DSM-IV and Semi-quantitative FFQ Greater exposure to added sugars and low-quality carbohydrates correlate with a higher risk of depression.
Ebrahimpour-Koujan et al. [55] 2019Cross-sectional studyn = 3362 adultsHospital Anxiety and Depression Scale and General Health Questionnaire-12 and Semi-quantitative Food Frequency QuestionnaireDepression was not associated with adherence to a low-carbohydrate diet.
Makhani et al. [56] 2021Cross-sectional studyn = 9728 adults Patient Health Questionnaire-9 (PHQ-9) and two 24 h dietary recall interviewsThe higher the ratio of carbohydrate-to-fibre intake in the diet, the higher the risk of depressive symptoms, which can be moderate to severe in severity.
Amirinejad et al. [57] 2022Cross-sectional studyn = 7384 adults Depression Anxiety Stress Scales and Validated Food Frequency QuestionnaireNo significant association was observed between the dietary glycaemic index (DGI) and glycaemic load (DGL) and the likelihood of depression.
Total macronutrients
Pooyan et al. [58] 2018Cross-sectional studyn = 265 adultsDepression Anxiety Stress Scales 21 (DASS-21) and Semi-quantitative Food Frequency Questionnaire and blood samples were taken, and biochemical measurements were takenA significant interaction was found between the high-protein and low-fat diets and the low-fat diet and the rs7041 polymorphism in groups with moderate and severe depression.
In healthy adults without chronic diseases, a high-protein, low-fat diet may interact with the VDBP genotype to reduce the risk of depression.
Oh et al. [59] 2020Cross-sectional studyn = 76,635
(60,935 from the United States and 15,700 from South Korea)
Patient Health Questionnaire-9 (PHQ-9) and 24 h dietary recall interviewIn both the United States and South Korea, people with low protein intake had a significantly higher risk of depression than those with normal protein intake.
When the proportion of kilocalories consumed from protein increased by 10%, the prevalence of depression was significantly reduced.
There was no significant association between fat intake and depression in either country. An association was observed between carbohydrate intake and the incidence of depression in the United States, but not in South Korea.
Eissenstat et al. [60] 2020Cross-sectional studyn = 4747 adultsPatient Health Questionnaire-9 (PHQ-9) and two 24 h dietary recall interviewsFor respondents of Hispanic origin, total protein intake and fats were negatively associated with depressive symptoms.
In Caucasians, the intake of dietary fibre was negatively associated with symptoms of depression.
Lee et al. [61] 2021Cross-sectional studyn = 6336 adults (3102 Korean adults and 3234 Americans)Patient Health Questionnaire-9 (PHQ-9) and 24 h dietary recall interviewA low intake of protein and dietary fibre as a result of food insecurity can increase the risk of depression. Adequate diet and food security can play an important role in the prevention of depression.
Water
Haghighatdoost et al. [62] 2018Cross-sectional studyn = 3327 adultsHospital Anxiety and Depression Scale and water consumption was assessed by asking about the number of glasses of water that were consumed daily (<2, 2–5, and ≥5 glasses of water/day)A significant inverse relationship was shown between water consumption and depression.
Drinking <2 glasses of water per day was associated with a 73% increased risk of depression in men and 54% in women.
Table 3. Assessment of dietary fatty acid intake and prevalence of depressive symptoms.
Table 3. Assessment of dietary fatty acid intake and prevalence of depressive symptoms.
AuthorsYear of PublicationType of StudyThe GroupAssessment of Depression and Dietary IntakeResults and Conclusions
Sánchez-Villegas et al. [70] 2018Cross-sectional studyn = 6874 adultsBeck Depression Inventory-II and 143-item Semi-quantitative Food-Frequency QuestionnaireTotal omega-3 fatty acid intake (approximately 0.5–1 g/day) was significantly associated with a lower incidence of depression.
Park et al. [71] 2020Cohort studyn = 2200 adult womenBeck Depression Inventory-II (BDI-II) and Center for Epidemiologic Studies-Depression scale (CES-D) assessment questionnaires, and n-3 FA intakes were assessed using a Semi-quantitative Food-Frequency QuestionnaireA higher intake of omega-3 fatty acids was associated with increased connectivity within the neural networks associated with emotion and attention, and increased connectivity between the regions of the brain associated with emotion control and cognitive processes. Omega-3 fatty acid intake may have an effect on brain function and possibly a role in the reduction of depressive symptoms in middle-aged women.
Zhang et al. [72] 2020Cross-sectional studyn = 17,431 adultsPHQ-9 (nine-item Patient Health Questionnaire) and two 24 h dietary recall interviewsA higher intake of omega-3 fatty acids was associated with a lower risk of depressive symptoms, while a higher intake of omega-6 fatty acids was associated with a higher risk of depressive symptoms.
A higher omega-6:omega-3 ratio was also associated with a higher risk of depressive symptoms.
Li et al. [73] 2020Cross-sectional studyn = 3054 adult womenCenter for Epidemiological Studies Depression Scale (CES-D) and Food Frequency Questionnaire (FFQ)A higher intake of omega-3 fatty acids was associated with a lower risk of depression in early perimenopausal women.
Berger et al. [74] 2020Cross-sectional studyn = 206 adultsPatient Health Questionnaire-9 (PHQ-9) and diet with a structured questionnaireHigher intakes of seafood and omega-3 fatty acids were associated with a lower risk of depressive symptoms.
A protective factor against depression may be the availability of fresh seafood in the local diet.
Chaves et al. [75] 2022Longitudinal studyn = 13,879 adultsThe Clinical Interview Schedule Revised (CIS-R) and Food Frequency Questionnaire (FFQ)The protective effect of omega-3s (total and subtypes) has been shown, with reductions of 2–65% in the risk of major depressive disorder. Consumption of all types of omega-3 fatty acids was lower among those with persistent depressive episodes.
Table 4. Main role of selected B vitamins in the nervous system.
Table 4. Main role of selected B vitamins in the nervous system.
Vitamin BEffects on the Nervous System and Risk of Depression
Vitamin B1
(thiamine)
Thiamine is an important coenzyme during the synthesis of neurotransmitters, such as acetylcholine and serotonin, for example.
The most important function of thiamine is considered to be that it makes a major contribution to cellular energy metabolism and, as an essential cofactor in carbohydrate metabolism, it helps to supply energy to nerve cells [84].
An inverse relationship has been shown between thiamine levels and depressive symptoms in adults [85].
Vitamin B6
(pyridoxine)
Pyridoxine functions as a cofactor in the pathways involved in myelin synthesis and enzymatic reactions, including the synthesis of neurotransmitters such as gamma-aminobutyric acid (GABA), serotonin, and dopamine [86].
Furthermore, it controls glutamate excitability and neuronal metabolism. Vitamin B6 and magnesium both modulate neurobiological mechanisms, leading to speculation that they may exert synergistic effects [87].
Pyridoxal-5-phosphate concentrations, the active form of vitamin B6, were measured in Hispanic adults in years 2 and 5 of the study, and it was observed that depressive symptoms were higher in those with low values [88].
Vitamin B9
(folic acid)
Folic acid is involved in the synthesis and metabolism of neurotransmitters associated with depression (serotonin, dopamine, norepinephrine). In addition, it plays a vital role in the regeneration of tetrahydrobiopterin (BH4), a cofactor essential for the formation of neurotransmitters [89].
An association has been shown between lower serum folic acid levels during pregnancy and prenatal depression [90].
Vitamin B12
(cobalamin)
A specific function of vitamin B12 is to participate in the DNA synthesis of myelin-producing oligodendrocytes and in the synthesis of myelin [83,85].
Cobalamin is a cofactor of the methionine synthase enzyme, which catalyses the reaction to transfer a methyl group to a homocysteine molecule. Methionine is formed, which is the precursor of S-adenosylmethionine (SAM). SAM plays an important role in the methylation processes necessary for the normal synthesis and/or metabolism of membrane phospholipids, DNA, RNA, neurotransmitters and for the normal function of the myelin sheaths of nerve fibres [91].
Vitamin B12 deficiency may be associated with impaired glutathione peroxidase activity elevated levels of free radicals. Furthermore, the prevalence of depression tends to be higher among vegetarians due to insufficient intake of vitamin B12 [92].
Table 5. Assessment of dietary intake of B vitamins and prevalence of depressive symptoms.
Table 5. Assessment of dietary intake of B vitamins and prevalence of depressive symptoms.
AuthorsYear of PublicationType of StudyThe GroupAssessment of Depression and Dietary IntakeResults and Conclusions
Vitamin B1
Duc et al. [97] 2021National cross-sectional surveyn = 34,700 adultsDepression was defined as physician diagnosis, the current presence or treatment for depression and 24 h dietary recall interview and a Semi-quantitative Questionnaire on Food Frequency Serum vitamin B1 concentrations were assessed and related to dietary intake. Low serum thiamine concentrations were associated with a high incidence of depressive symptoms.
Increased daily vitamin B1 intake was negatively associated with the appearance of depression.
Nguyen et al. [98] 2022National cross-sectional surveyn = 16,371 adultsDepression was defined based on the diagnosis of the physician or the current presence or treatment of depression, and daily food intake was calculated using the 24 h recall method and a Semi-quantitative Food Frequency Questionnaire (FFQ)A higher dietary intake of vitamin B1, B3, or A reduces the risk of depression in a nationally representative Korean cohort.
Vitamin B6
Kafeshani et al. [99] 2020Cross-sectional studyn = 3362 adultsHospital Anxiety and Depression Scale (HADS)
and a validated, 106-item Food Frequency Questionnaire (FFQ)
The average intake of vitamin B6 (mg/day) was lower in people with depression.
A lower intake of vitamin B6 in the general population and among women was associated with a higher likelihood of depression.
Odai et al. [100] 2020Cross-sectional studyn = 289 adult womenHospital Anxiety and Depression Scale (HADS)
and self-administered diet history questionnaire (BDHQ)
Symptoms of moderate-to-severe depression were associated with a lower dietary intake of vitamin B6.
Symptoms of depression may be reduced by increasing your intake of vitamin B6.
Vitamins B9 and B12
Khosravi et al. [101] 2020Clinical-control studyn = 260 women (87 depressed and 173 healthy) and 70 men (22 depressed and 48 healthy)The major depressive disorder(s) of the participants was diagnosed by psychiatrists using the criteria of DSM-IV and for the control group Beck Depression Inventory questionnaire (BDI-II), and the dietary intake in the last 12 months was evaluated using a Semi-quantitative Food Frequency Questionnaire (FFQ).In addition to dietary nutrient intake, their serum concentrations were evaluated and related to each other.
An unhealthy diet was associated with a higher risk of depression through a reduction in the serum levels of vitamins B9 and B12.
Zheng et al. [102] 2020Cross-sectional studyn = 19,244 adultsPatient Health Questionnaire-9 (PHQ-9) and 24 h dietary recall interviewSynthetic folic acid was not associated with depressive symptoms, but total and natural folate intakes were inversely associated with depressive symptoms.
Mahdavifar et al. [103] 2021A population-based prospective cohort studyn = 7387 Iranian adultsIranian validated version of depression, anxiety, and
stress scale questionnaire 21 (DASS 21) and Semi-quantitative Food Frequency Questionnaire (DS-FFQ)
Low intakes of B vitamins, including folic acid, vitamin B6, and vitamin B12, were associated with higher depressive symptoms.
Higher biotin intake was significantly associated with lower incidence of depressive symptoms.
Table 6. Assessment of dietary intake and serum vitamin D levels and prevalence of depressive symptoms.
Table 6. Assessment of dietary intake and serum vitamin D levels and prevalence of depressive symptoms.
AuthorsYear of PublicationType of StudyThe GroupAssessment of Depression and Dietary IntakeResults and Conclusions
Vitamin D
Pooyan et al. [58]2018Cross-sectional studyn = 265 adultsDepression Anxiety Stress Scales 21 (DASS-21) and Semi-quantitative Food Frequency Questionnaire (FFQ)In healthy adults without chronic disease, a high-protein/low-fat diet may interact with the genotype of vitamin D-binding protein VDBP to reduce the risk of depression.
Jahrami et al. [118] 2020Clinical-control studyn = 192 participants: 96 patients with depression and 96 age- and sex-matched controls Beck Depression Inventory-II (BDI-II) and Food Frequency Questionnaire (FFQ) (covering 102 foods distributed on 38 items/groups)Depressed patients have significantly lower serum vitamin D levels.
Depressed patients appeared to have statistically significantly less vitamin D from sunlight sources, even though dietary vitamin D intake was the same in both groups. Approximately 80% of depressed patients and 70% of controls have been shown not to take adequate daily doses of vitamin D.
Table 7. Assessment of dietary mineral intake and prevalence of depressive symptoms.
Table 7. Assessment of dietary mineral intake and prevalence of depressive symptoms.
AuthorsYear of PublicationType of StudyThe GroupAssessment of Depression and Dietary IntakeResults and Conclusions
Magnesium
Anjom-Shoae et al. [147] 2018Cross-sectional studyn = 3172 adults Hospital Anxiety and Depression Scale (HADS) and dish-based 106-item Semi-quantitative FFQ (DS-FFQ)Among normal-weight men and overweight women, a significant inverse association was found between magnesium intake and depression.
Sun et al. [148]2019Cross-sectional studyn = 17,730 adults from the National Health and Nutrition Examination SurveyPatient Health Questionnaire (PHQ-9) and two 24 h dietary recall interviewsLower magnesium intake was associated with a higher risk of depression, particularly in the female group.
In all age groups, the inverse association between dietary magnesium intake and risk of depression was statistically significant.
Chou et al. [149] 2023Cross-sectional studyn = 4615 adults5-Item Brief Symptom Rating Scale (BSRS-5) and Serum Magnesium (mg/dL) and dietary magnesium intake (mg)—24 h dietary recall questionnaireSerum magnesium concentration was inversely correlated with the occurrence of depressive symptoms, which was not shown for the dietary magnesium intake.
Serum magnesium was poorly correlated with dietary magnesium. The level of serum magnesium was negatively associated with depressive symptoms in the sample, in the men, but not in the women.
Zinc
Hajianfar et al. [150] 2021Cross-sectional studyn = 142 female studentsThe Beck Depression Inventory-II (BDI-II) and Semi-quantitative Food Frequency Questionnaire (FFQ)In Iranian female students, an inverse association was observed between dietary zinc intake and mood disorders, including depression, and some indicators of sleep disturbance.
Hu et al. [151] 2022Cross-sectional studyn = 31,839 adultsPatient Health Questionnaire-9 (PHQ-9 and two 24 h dietary recall interviewsEspecially in the female population, low dietary intakes of zinc and vitamin A were significantly associated with depression. In the low zinc intake group, the risk of depression was significantly reduced with increased total vitamin A intake.
Selenium
Ghimire et al. [152] 2019Cross-sectional studyn = 7725 adult participants in the National Health and Nutrition Examination Survey (NHANES)Patient Health Questionnaire-9 (PHQ-9) and 24 h dietary recall interview An inverse relationship was observed between participants’ dietary selenium intake and depressive symptoms.
There was no association between serum selenium levels and depressive symptoms.
Ferreira de Almeida et al. [153] 2021Cross-sectional studyn = 736 adult farmersMini-International Neuropsychiatric Interview and three 24 h dietary recall interviewsA high intake of selenium is associated with a lower incidence of depression, even after taking into account sociodemographic variables, lifestyle factors, and pesticide poisoning.
Copper
Nakamura et al. [154] 2019Cross-sectional studyn = 2089 adultsKessler’s six-item psychological distress scale (K6) and the FFQ include 87 food items and ask about the usual consumption rates and portion sizes during the previous month.Low intakes of zinc, copper, and manganese were associated with depressive symptoms.
For calcium, magnesium, and iron, the inverse relationship was not statistically significant.
Iron
Li et al. [155] 2018Cross-sectional studyn = 14,834 adultsPatient Health Questionnaire (PHQ-9) and 24 h dietary recallParticipants with depression had significantly lower total daily zinc, iron, copper, selenium, and energy intakes than those without depression. Higher zinc, iron, copper, and selenium intake was negatively associated with depression, and negative associations with copper and selenium intake remained statistically significant after considering potential confounders.
Calcium
Shen et al. [156] 2023Cross-sectional studyn = 14,971 adultsPatient Health Questionnaire (PHQ-9) and 24 h dietary recallEven after adjusting for a large number of potential confounders, calcium intake was negatively associated with the risk of depressive symptoms. The incidence of depressive symptoms decreased as calcium intake increased.
Various Minerals
Sánchez-Villegas et al. [157] 2018Cohort studyn = 13,983 students136-item validated Semi-quantitative Food Frequency Questionnaire (FFQ) and structured clinical interview for DSM-IV (SCID-I)A deficiency of 4 nutrients at baseline increased the risk of depression (folic acid, magnesium, calcium, and potassium) in this longitudinal study of a middle-aged population.
Salehi-Abargouei et al. [158] 2019Cross-sectional studyn = 3846 adults Hospital Anxiety and Depression Scale (HADS) and Semi-quantitative Food Frequency Questionnaire (FFQ)It has been shown that higher intakes of B12, zinc, phosphorus, saturated fats, cholesterol, B5, and B6 are associated with a reduced risk of major depression in men and a reduced risk of psychological distress in women.
Yun et al. [159]2021Cross-sectional studyn = 10,106 adultsPatient Health Questionnaire-9 (PHQ-9) and nutrient intake and dietary habit information of the K-NHANES were used as independent variables.Sugar, sodium, vitamin A, water, fat, saturated fatty acids, omega-6 fatty acids, dietary fibre, and frequency of breakfast, lunch, dinner, and eating out were significantly associated with depression.
Ferriani et al. [160] 2022Longitudinal studyn = 14,737 adultsClinical Interview Schedule Revised (CIS-R) and Food Frequency Questionnaire (FFQ)A significant inverse relationship was found between depression and a higher intake of selenium, zinc, vitamins B6 and B12 in the sample.
Among women, a similar pattern of correlation was observed, in addition to higher intakes of vitamins A and C.
Among men, a significant inverse relationship between depression was only observed with vitamin B12 and B6 intake. The incidence and severity of depression may be reduced by increasing intake of selected micronutrients.
Table 8. Summary of the effects of the described nutrients on the risk of depression.
Table 8. Summary of the effects of the described nutrients on the risk of depression.
NutrientConclusions
ProteinsHigher total protein consumption as well as that specifically derived from milk and dairy products might potentially lower the susceptibility to depressive symptoms. No benefit has been shown for protein intake from animal sources [47,48]. A beneficial effect of a higher supply of tryptophan in the diet has been shown to decrease the risk of depression [49,50,51].
A diet with an increased supply of protein relative to other macronutrients may have a beneficial effect on the risk of depression in adults who do not have any chronic diseases [58,59,60,61].
FatsNo association has been observed between total fat consumption and the manifestation of depressive symptoms [52,53,59], although not all results are conclusive [58,60].
CarbohydratesGreater exposure to added sugars, low-quality carbohydrates, and low dietary fibre intake have been shown to correlate with a higher risk of depression [54,57]. No significant association was observed between the dietary glycaemic index and the dietary glycaemic load and the likelihood of depression [57].
WaterTo date, it has not been conclusively demonstrated that dietary water intake directly affects the risk of depression; however, dehydration can exacerbate, for example, fatigue and depression. Therefore, it is worth ensuring that the body is adequately hydrated to avoid the negative effects of dehydration [46,62].
Polyunsaturated fatty acidsAll the publications cited showed a beneficial effect of increased omega-3 fatty acid intake to prevent the onset of depressive symptoms in different groups [70,71,72,73,74,75].
Vitamins of the B groupLow dietary and/or serum levels of vitamins B1, B6, B9, and B12 have been associated with a higher prevalence of depressive symptoms [97,98,99,100,101,102,103]. The findings suggest that the intake of adequate amounts of B vitamins may have a positive impact on mental health and reduce the risk of depressive symptoms.
Vitamin DDepressed patients have significantly lower serum vitamin D levels [58,118]. It has been shown that approximately 80% of depressed patients do not take adequate daily doses of vitamin D [118].
Mineral ComponentsDietary deficiencies in magnesium, zinc, selenium, copper, and manganese have been associated with a greater likelihood of depression [147,148,149,150,151,152,153,154,155,156,157,158,159,160]. Both excess and deficiency of copper and iron may affect the risk of depression [135,145,154,155].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zielińska, M.; Łuszczki, E.; Dereń, K. Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023). Nutrients 2023, 15, 2433. https://doi.org/10.3390/nu15112433

AMA Style

Zielińska M, Łuszczki E, Dereń K. Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023). Nutrients. 2023; 15(11):2433. https://doi.org/10.3390/nu15112433

Chicago/Turabian Style

Zielińska, Magdalena, Edyta Łuszczki, and Katarzyna Dereń. 2023. "Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023)" Nutrients 15, no. 11: 2433. https://doi.org/10.3390/nu15112433

APA Style

Zielińska, M., Łuszczki, E., & Dereń, K. (2023). Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023). Nutrients, 15(11), 2433. https://doi.org/10.3390/nu15112433

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop